Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Shock. 2022 Feb 1;57(2):246–255. doi: 10.1097/SHK.0000000000001894

Fig. 5. M3 treatment ameliorates local and systemic inflammation.

Fig. 5.

(A) MPO activity was determined spectrophotometrically. The mRNA levels of (B) IL-6, (C) MIP-2, and (D) COX-2 were measured by RT-qPCR. Levels were normalized to β-actin. The serum levels of (E) IL-6 were measured by ELISA (n = 8/group). Data expressed as means ± SE and compared by one-way ANOVA and SNK method (*P ≤ 0.05 versus sham; #P ≤ 0.05 vs vehicle).